Free Trial
NASDAQ:IRWD

Ironwood Pharmaceuticals (IRWD) Stock Price, News & Analysis

Ironwood Pharmaceuticals logo
$0.74 +0.00 (+0.04%)
As of 07/3/2025 03:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Ironwood Pharmaceuticals Stock (NASDAQ:IRWD)

Key Stats

Today's Range
$0.73
$0.77
50-Day Range
$0.57
$0.97
52-Week Range
$0.53
$7.11
Volume
1.03 million shs
Average Volume
2.57 million shs
Market Capitalization
$119.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.78
Consensus Rating
Hold

Company Overview

Ironwood Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

IRWD MarketRank™: 

Ironwood Pharmaceuticals scored higher than 93% of companies evaluated by MarketBeat, and ranked 79th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ironwood Pharmaceuticals has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 1 buy rating, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Ironwood Pharmaceuticals has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Ironwood Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for Ironwood Pharmaceuticals are expected to grow by 150.00% in the coming year, from $0.10 to $0.25 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ironwood Pharmaceuticals is -3.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ironwood Pharmaceuticals is -3.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Ironwood Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    4.91% of the float of Ironwood Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Ironwood Pharmaceuticals has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ironwood Pharmaceuticals has recently decreased by 7.05%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ironwood Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Ironwood Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.91% of the float of Ironwood Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Ironwood Pharmaceuticals has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ironwood Pharmaceuticals has recently decreased by 7.05%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 1 people have searched for IRWD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Ironwood Pharmaceuticals to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ironwood Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.70% of the stock of Ironwood Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Ironwood Pharmaceuticals' insider trading history.
Receive IRWD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

IRWD Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Ironwood Raises 2025 Adj. EBITDA Outlook
Ironwood backs FY25 revenue view $260M-$290M, consensus $287.07M
See More Headlines

IRWD Stock Analysis - Frequently Asked Questions

Ironwood Pharmaceuticals' stock was trading at $4.43 at the beginning of the year. Since then, IRWD shares have decreased by 83.3% and is now trading at $0.74.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) posted its earnings results on Wednesday, May, 7th. The biotechnology company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.09. The biotechnology company earned $41.14 million during the quarter, compared to analysts' expectations of $67.02 million. Ironwood Pharmaceuticals had a negative trailing twelve-month return on equity of 1.87% and a negative net margin of 9.89%.

Shares of IRWD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ironwood Pharmaceuticals investors own include American Water Works (AWK), Humana (HUM), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/07/2025
Today
7/05/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:IRWD
Employees
220
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.78
High Stock Price Target
$14.00
Low Stock Price Target
$0.70
Potential Upside/Downside
+546.4%
Consensus Rating
Hold
Rating Score (0-4)
2.13
Research Coverage
8 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
7.40
P/E Growth
N/A
Net Income
$880 thousand
Pretax Margin
7.54%

Debt

Sales & Book Value

Annual Sales
$351.41 million
Cash Flow
$0.05 per share
Price / Cash Flow
15.49
Book Value
($1.88) per share
Price / Book
-0.39

Miscellaneous

Free Float
141,269,000
Market Cap
$119.75 million
Optionable
Optionable
Beta
0.30
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:IRWD) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners